Share to
Details
Safety
Related
Technical Documents
Articles
reviews
Consult
returns
Product details
名称
Recombinant Human CXCL7/NAP-2 Protein
别名
重组人CXCL7/NAP-2蛋白 | 重组人趋化因子(C-X-C基序)7蛋白 | 重组人中性粒细胞活化蛋白2
英文别名
Beta-TG | connective tissue-activating peptide III | CTAP III | CTAP3CTAP-III | CTAPIII | CXC chemokine ligand 7 | C-X-C motif chemokine 7 | CXCL7 | CXCL7b-TG1 | LA-PF4 | LDGFTC1 | Leukocyte-derived growth factor | low-affinity platelet factor IV | Macrop
货号
rp181578-10μg
包装规格
10μg
级别
无载体
浓度
≥90%(SDS-PAGE)
生化机理
Neutrophil Activating Peptide 2 (NAP-2), Connective Tissue Activating Protein III (CTAP-III) and beta -thrombogulin ( beta -TG), are proteolytically processed carboxyl-terminal fragments of platelet basic protein (PBP) which is found in the alpha-granules of human platelets. NAP-2 is a member of the CXC chemokines. Similar to other ELR domain containing CXC chemokines such as IL-8 and the GRO proteins, NAP-2 has been shown to bind CXCR2 and to chemoattract and activate neutrophils. Although CTAP-III, beta -TG and PBP represent amino-terminal extended variants of NAP-2 and possess the same CXC chemokine domains, these proteins do not exhibit NAP-2 activity. It has been shown that the additional amino-terminal residues of CTAP-III masks the critical ELR receptor binding domain that is exposed on NAP-2 and may account for lack of NAP-2 activity. Post-translational: Proteolytic removal of residues 1-9 produces the active peptide connective tissue-activating peptide III (CTAP-III) (low-affinity platelet factor IV (LA-PF4)).Proteolytic removal of residues 1-13 produces the active peptide beta-thromboglobulin, which is released from platelets along with platelet factor 4 and platelet-derived growth factor. NAP-2(1-66) is produced by proteolytical processing, probably after secretion by leukocytes other than neutrophils. NAP-273 and NAP-274 seem not be produced by proteolytical processing of secreted precursors but are released in an active form from platelets.
生物活性
Testing in progress
来源
重组表达
预测分子量
7.6 kDa
蛋白标签
No tag
SDS-PAGE
10.2 kDa, under reducing conditions; 10.7 & 11.2 kDa, under non-reducing conditions.
表达系统
E. coli Accession #: P02775 | E. coli
内毒素水平
<1.0 EU/μg
种属
人(Human)
氨基酸
59-128 aa
序列
AELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDESAD
无动物源
No
无载体
Yes
Safety
「No Dangerous Attributes」
Related
「No upstream and downstream information yet」
Technical Documents
「No technical documents」
Articles
「No related articles yet」
user reviews
Loading...
Consultation

Warm reminder:

Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.!

After Sales Services

Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.

Service Hotline:400-6226-992 ,We will handle it for you as soon as possible, thank you for your support and trust.!

Research chemical ≥90%

Research chemical ≥90%; supplied for laboratory research, analysis, inspection, and scientific procurement use; specifications: ≥90%.

item number:rp181578-10μg
Product model:10μg
level: ≥90%
Lead Time:30days
sold 281 Items
Ask Solution engineer
Specifications:

10μg

Qty

Recommended for you